Literature DB >> 29276745

Frequencies of alleles, genotypes and haplotypes of two polymorphisms in the clusterin gene in the Russian elderly population categorized by cognitive performance.

Anna V Bocharova1, Kseniya V Vagaitseva1,2, Oksana A Makeeva1,3, Andrey V Marusin1, Vadim A Stepanov1,2.   

Abstract

This article contains data on the frequencies of alleles, genotypes and haplotypes of the single nucleotide polymorphisms (SNPs) rs2279590 and rs1532278 in the CLU gene in a cohort of normal elderly from the Russian population. The SNPs have been reported to be associated with Alzheimer's disease and cognitive functions in genome-wide and candidate genes association studies. Cognitive performance in sample set was estimated by the Montreal Cognitive Assessment (MoCA). The frequencies of alleles, genotypes and haplotypes of two SNPs were calculated in 3 groups: total sample set, sample set with MoCA score less than 21 (the first quartile) and group with MoCA score more than 24 (the fourth quartile).

Entities:  

Keywords:  Alzheimer's disease; CLU; Cognitive performance; Elderly; MoCa; Russian population

Year:  2017        PMID: 29276745      PMCID: PMC5738205          DOI: 10.1016/j.dib.2017.12.019

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data The variation in CLU gene may play a role in genetics of cognition and normal ageing. The data on the allele, genotype and haplotype frequencies are an important resource for understanding genetic structure of different populations. The frequencies of alleles, genotypes and haplotypes for rs2279590 and rs1532278 in the CLU gene in the Russian population were not previously known. The data can be used for comparative genetic studies of neurodegenerative diseases such as Alzheimer's disease, as well as cognitive performance in various populations.

Data

The data represent the frequencies of alleles, genotypes and haplotypes for single nucleotide polymorphisms (SNPs) rs2279590 and rs1532278 in human clusterin gene (CLU) associated to Alzheimer's diseases in previously published genome-wide and candidate genes association studies [1], [2], [3], [4], [5]. Russian sample set was classified into three groups according to their MoCA scores: all samples, the first quartile (total MoCA ≤ 20), the fourth quartile (total MoCa ≥ 25). The frequencies of alleles and genotypes are presented in Table 1. The description of haplotype and its frequencies are listed in Table 2.The structure of linkage disequilibrium of rs2279590 and rs1532278 in clusterin gene (CLU) is demonstrated in Fig. 1.
Table 1

The frequencies of alleles and genotypes for single nucleotide polymorphisms (SNPs) rs2279590 and rs1532278 in clusterin gene (CLU) in Russian elderly population.

SNP Genotype or alleleAll (n=700)
The first quartile (total MoCA ≤ 20) (n=195)
The fourth quartile (total MoCa ≥ 25) (n=195)
nGF or AFnGF or AFnGF or AF
rs2279590
TT980.1400280.1436240.1231
CT3530.50431010.51791030.5282
CC2490.3557660.3385680.3484
T5490.39211570.40261510.3872
C8510.60792330.59742390.6128
rs1532278
TT910.1300260.1333220.1128
CT3500.50001020.5231990.5077
CC2590.3700670.3436740.3795
T5320.38001540.39491430.3667
C8680.62002360.60512470.6333

GF, Genotypic frequency; AF, Allelic frequency.

Table 2

The frequencies of haplotypes for single nucleotide polymorphisms (SNPs) rs2279590 and rs1532278 in clusterin gene (CLU) in Russian elderly population.

Haplotype (rs2279590, rs1532278)All (n=700) frequenciesThe first quartile (total MoCA ≤ 20) (n=195) frequenciesThe fourth quartile (total MoCa ≥ 25) (n=195) frequencies
CC0.6060.5970.613
TT0.3780.3950.367
TC0.0140.0080.021
CT0.002
Fig. 1

The structure of linkage disequilibrium of rs2279590 and rs1532278 in clusterin gene (CLU). Linkage disequilibrium was measured by Lewontin's coefficient D′. The dark red (D′=1) indicates that there exists strong pairwise LD between SNPs. A) All sample set (r2=0.932). B) The first quartile (total MoCA ≤ 20) (r2=0.968). C) The fourth quartile (total MoCa ≥ 25) (r2=0.916).

The structure of linkage disequilibrium of rs2279590 and rs1532278 in clusterin gene (CLU). Linkage disequilibrium was measured by Lewontin's coefficient D′. The dark red (D′=1) indicates that there exists strong pairwise LD between SNPs. A) All sample set (r2=0.932). B) The first quartile (total MoCA ≤ 20) (r2=0.968). C) The fourth quartile (total MoCa ≥ 25) (r2=0.916). The frequencies of alleles and genotypes for single nucleotide polymorphisms (SNPs) rs2279590 and rs1532278 in clusterin gene (CLU) in Russian elderly population. GF, Genotypic frequency; AF, Allelic frequency. The frequencies of haplotypes for single nucleotide polymorphisms (SNPs) rs2279590 and rs1532278 in clusterin gene (CLU) in Russian elderly population.

Experimental design, materials and methods

Subjects

The study protocol was approved by the Ethics Committee of the Research Institute of Medical Genetics, Tomsk, Russian Federation. Sample of 700 elderly individuals without dementia and neurological diseases (age range 59–89 years, mean age 70.8 years) of Russian descent was randomly selected from a population-based cohort study on primary prevention of Alzheimer's disease in Tomsk, Russia [6], [7]. All of the studied individuals were Caucasians from the same ethnic (Russian) and geographical origin, living in the Tomsk region of Russian Federation. Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA) [8]. MoCA scores ranged between 0–30 points, and higher scores indicate better cognitive function. The data included 3 groups: total sample set, sample set with MoCA score less than 21 (the first quartile) and group with MoCA score more than 24 (the fourth quartile).

DNA extraction

Genomic DNA was extracted from the peripheral venous blood using phenolchloroform extraction.

Genotyping

All 700 samples were prepared for genotyping using Sequenom iPLEX Assay following the recommended protocol by the manufacturer (Agena Bioscience™), and then were genotyped by MALDI/TOF mass spectrometry using Sequenom MassARRAY 4.0 platform (Agena Bioscience™).

Statistical analyses

Genotype distributions for both SNPs were in Hardy-Weinberg equilibrium, estimated by chi-square test. No significant differences in allele frequencies between the first and the forth age adjusted MoCA quartiles were found for rs2279590 (χ2=0.19, p=0.66) and rs1532278 (χ2=0.66, p=0.42). The linkage disequilibrium (LD) between rs2279590 and rs1532278 was quantified using Haploview version 4.2 software. Haplotype frequencies were determined using the EM algorithm. The LD block structure was determined using the Solid Spine of the LD algorithm [9] provided by the Haploview 4.2. The degree of genetic linkage between the 2 SNPs in 3 groups was estimated as Lewontin's coefficient D’ and Pearson's correlation coefficient r2, where no color (D′=0) indicates that LD is weak or nonexistent and the dark red (D′=1) indicates that there exists strong pairwise LD between SNPs (Fig. 1).

Funding sources

The work was supported by the Russian Science Foundation (Grant no. 16-14-00020).
Subject areaHuman Genetics
More specific subject areaGenetics of cognitive functions
Type of dataTable and figure
How data was acquiredMALDI/TOF mass spectrometry using Sequenom MassARRAY 4.0 platform (Agena Bioscience™)
Data formatAnalyzed
Experimental factorsGenomic DNA was extracted from whole blood samples using phenol–chloroform extraction.
Experimental featuresGenotyping of two SNPs was carried out using Sequenom iPLEX Assay following the recommended protocol by the manufacturer (Agena Bioscience™).
Data source locationTomsk, Russian Federation
Data accessibilityThe data is available within this article
  8 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].

Authors:  S A Golenkina; A Iu Gol'tsov; I L Kuznetsova; A P Grigorenko; T V Andreeva; D A Reshetov; S S Kunizheva; L I Shagam; I Iu Morozova; I V Goldenkova-Pavlova; Kh Shimshilashvili; A O Viacheslavova; G Faskhutdinova; A É Gareeva; A G Zaĭnullina; É K Khusnutdinova; V P Puzyrev; V A Stepanov; A V Kolotvin; L M Samokhodskaia; N D Selezneva; S I Gavrilova; E I Rogaev
Journal:  Mol Biol (Mosk)       Date:  2010 Jul-Aug

3.  [Biochip for determination of genetic markers of sporadic Alzheimer's disease in the Russian Slavic population].

Authors:  I I Nizamutdinov; T V Andreeva; V A Stepanov; A V Marusin; E I Rogaev; A S Zasedatelev; T V Nasedkina
Journal:  Mol Biol (Mosk)       Date:  2013 Nov-Dec

4.  A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial.

Authors:  Kathleen M Hayden; Oksana A Makeeva; L Kristin Newby; Brenda L Plassman; Valentina V Markova; Ashley Dunham; Heather R Romero; Zarui A Melikyan; Cassandra M Germain; Kathleen A Welsh-Bohmer; Allen D Roses
Journal:  Alzheimers Dement       Date:  2014-07-22       Impact factor: 21.566

5.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.

Authors:  Jean-Charles Lambert; Simon Heath; Gael Even; Dominique Campion; Kristel Sleegers; Mikko Hiltunen; Onofre Combarros; Diana Zelenika; Maria J Bullido; Béatrice Tavernier; Luc Letenneur; Karolien Bettens; Claudine Berr; Florence Pasquier; Nathalie Fiévet; Pascale Barberger-Gateau; Sebastiaan Engelborghs; Peter De Deyn; Ignacio Mateo; Ana Franck; Seppo Helisalmi; Elisa Porcellini; Olivier Hanon; Marian M de Pancorbo; Corinne Lendon; Carole Dufouil; Céline Jaillard; Thierry Leveillard; Victoria Alvarez; Paolo Bosco; Michelangelo Mancuso; Francesco Panza; Benedetta Nacmias; Paola Bossù; Paola Piccardi; Giorgio Annoni; Davide Seripa; Daniela Galimberti; Didier Hannequin; Federico Licastro; Hilkka Soininen; Karen Ritchie; Hélène Blanché; Jean-François Dartigues; Christophe Tzourio; Ivo Gut; Christine Van Broeckhoven; Annick Alpérovitch; Mark Lathrop; Philippe Amouyel
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

6.  Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.

Authors:  Tau Ming Liew; Lei Feng; Qi Gao; Tze Pin Ng; Philip Yap
Journal:  J Am Med Dir Assoc       Date:  2014-10-03       Impact factor: 4.669

7.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

8.  A novel Alzheimer disease locus located near the gene encoding tau protein.

Authors:  G Jun; C A Ibrahim-Verbaas; M Vronskaya; J-C Lambert; J Chung; A C Naj; B W Kunkle; L-S Wang; J C Bis; C Bellenguez; D Harold; K L Lunetta; A L Destefano; B Grenier-Boley; R Sims; G W Beecham; A V Smith; V Chouraki; K L Hamilton-Nelson; M A Ikram; N Fievet; N Denning; E R Martin; H Schmidt; Y Kamatani; M L Dunstan; O Valladares; A R Laza; D Zelenika; A Ramirez; T M Foroud; S-H Choi; A Boland; T Becker; W A Kukull; S J van der Lee; F Pasquier; C Cruchaga; D Beekly; A L Fitzpatrick; O Hanon; M Gill; R Barber; V Gudnason; D Campion; S Love; D A Bennett; N Amin; C Berr; Magda Tsolaki; J D Buxbaum; O L Lopez; V Deramecourt; N C Fox; L B Cantwell; L Tárraga; C Dufouil; J Hardy; P K Crane; G Eiriksdottir; D Hannequin; R Clarke; D Evans; T H Mosley; L Letenneur; C Brayne; W Maier; P De Jager; V Emilsson; J-F Dartigues; H Hampel; M I Kamboh; R F A G de Bruijn; C Tzourio; P Pastor; E B Larson; J I Rotter; M C O'Donovan; T J Montine; M A Nalls; S Mead; E M Reiman; P V Jonsson; C Holmes; P H St George-Hyslop; M Boada; P Passmore; J R Wendland; R Schmidt; K Morgan; A R Winslow; J F Powell; M Carasquillo; S G Younkin; J Jakobsdóttir; J S K Kauwe; K C Wilhelmsen; D Rujescu; M M Nöthen; A Hofman; L Jones; J L Haines; B M Psaty; C Van Broeckhoven; P Holmans; L J Launer; R Mayeux; M Lathrop; A M Goate; V Escott-Price; S Seshadri; M A Pericak-Vance; P Amouyel; J Williams; C M van Duijn; G D Schellenberg; L A Farrer
Journal:  Mol Psychiatry       Date:  2015-03-17       Impact factor: 15.992

  8 in total
  1 in total

1.  Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium.

Authors:  Thomas G Schulze; Аleksandr О Kibitov; Olga Yu Fedorenko; Vera E Golimbet; Svetlana А Ivanova; Аnastasia Levchenko; Raul R Gainetdinov; Arkady V Semke; German G Simutkin; Аnna E Gareeva; Аndrey S Glotov; Anna Gryaznova; Ivan Y Iourov; Evgeny M Krupitsky; Igor N Lebedev; Galina E Mazo; Vasily G Kaleda; Lilia I Abramova; Igor V Oleichik; Yulia A Nasykhova; Regina F Nasyrova; Anton E Nikolishin; Evgeny D Kasyanov; Grigory V Rukavishnikov; Ilgiz F Timerbulatov; Vadim M Brodyansky; Svetlana G Vorsanova; Yury B Yurov; Tatyana V Zhilyaeva; Anzhelika V Sergeeva; Elena A Blokhina; Edwin E Zvartau; Anna S Blagonravova; Lyubomir I Aftanas; Nikolay А Bokhan; Zurab I Kekelidze; Tatyana V Klimenko; Irina P Anokhina; Elza K Khusnutdinova; Tatyana P Klyushnik; Nikolay G Neznanov; Vadim A Stepanov
Journal:  Mol Psychiatry       Date:  2019-01-21       Impact factor: 15.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.